Revenue: The sum of all revenue fields included for a company's operating activities.
Standard BioTools Inc. (LAB) had Revenue of $174.43M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$174.43M |
$-184.90M |
|
$90.17M |
|
$84.26M |
|
$349.67M |
|
$-175.24M |
|
$36.92M |
|
$-138.31M |
|
$-163.53M |
|
$-138.88M |
|
$-138.88M |
|
$-138.88M |
|
$-163.99M |
|
$-175.24M |
|
$-165.81M |
|
353.25M |
|
353.25M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$375.88M |
|
$42.56M |
|
$236.46M |
|
$612.34M |
|
$65.89M |
|
$0.30M |
|
$74.73M |
|
$140.62M |
|
$471.72M |
|
$331.47M |
|
$471.72M |
|
377.53M |
|
| Cash Flow Statement Financials | |
$-143.45M |
|
$363.17M |
|
$-102.62M |
|
$52.50M |
|
$168.82M |
|
$116.32M |
|
$31.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.70 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
48.31% |
|
-100.46% |
|
-100.46% |
|
-95.06% |
|
-79.29% |
|
-106.00% |
|
$-151.81M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
2.21 |
|
5.19 |
|
70.32 |
|
-29.44% |
|
-41.90% |
|
-22.68% |
|
-29.42% |
|
$1.25 |
|
$-0.43 |
|
$-0.41 |
|